Levy, Emile; Gabriel, Sylvie; Dinet, Jerome - In: PharmacoEconomics 21 (2003) 9, pp. 651-659
Background: The clinical manifestations of atherothrombotic disease include ischaemic heart disease (including myocardial infarction [MI]) and cerebrovascular disease (including ischaemic stroke [IS]). Although costs generated by the clinical manifestations of atherothrombotic disease represent...